Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:UROV

Urovant Sciences (UROV) Stock Price, News & Analysis

Urovant Sciences logo

About Urovant Sciences Stock (NASDAQ:UROV)

Advanced Chart

Key Stats

Today's Range
$16.24
$16.24
50-Day Range
$16.19
$16.24
52-Week Range
$7.15
$16.26
Volume
N/A
Average Volume
114,469 shs
Market Capitalization
$531.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UROV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urovant Sciences and its competitors with MarketBeat's FREE daily newsletter.

UROV Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
PM360 Announces 2023 Trailblazer Award Winners
See More Headlines

UROV Stock Analysis - Frequently Asked Questions

Urovant Sciences Ltd. (NASDAQ:UROV) released its earnings results on Thursday, February, 11th. The company reported ($1.46) earnings per share for the quarter, topping analysts' consensus estimates of ($1.59) by $0.13.

Urovant Sciences (UROV) raised $150 million in an initial public offering on Thursday, September 27th 2018. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Urovant Sciences investors own include Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Xeris Biopharma (XERS), Akero Therapeutics (AKRO), Aldeyra Therapeutics (ALDX), Idera Pharmaceuticals (IDRA) and Kaleido Biosciences (KLDO).

Company Calendar

Last Earnings
2/11/2021
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:UROV
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$146.74 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($1.90) per share
Price / Book
-8.55

Miscellaneous

Free Float
N/A
Market Cap
$531.75 million
Optionable
Not Optionable
Beta
2.36
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:UROV) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners